To compare the two drugs sugammadex and neostigmine in reversing the patient , who is paralysed by vecuronium
Phase 4
- Conditions
- Health Condition 1: 4- Measurement and Monitoring
- Registration Number
- CTRI/2024/08/071849
- Lead Sponsor
- Institute of medical sciences, SUM hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients undergoing elective surgeries of age greater than 60 years and patients of ASA 1 and ASA 2
Exclusion Criteria
Patients who are not willing to give consent for the study, patient known allergic to narcotics, muscle relaxants, or other medication used during general anaesthesia, patients with anticipation of difficult airway, patients on drugs which are known to interact with neuromuscular blocking drugs, patients with significant renal dysfunction, patients who are known or suspected neuromuscular disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the time taken from start of study drug injection to train of four 0.9 ratioTimepoint: Check train of four count every twenty minutes for one hour
- Secondary Outcome Measures
Name Time Method ook for other adverse effects of the drug such as nausea, vomiting, altered tasteTimepoint: Check for every twenty minutes for one hour